Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02704351 · ClinicalTrials.gov registry record
Suggamadex and Fast-track Cardiac Anesthesia in a Developing Country
A clinical trial, sponsored by Joseph D. Tobias.
- Completed
- Registry status
- 14
- Enrollment target
NCT02704351: Completed study, sponsored by Joseph D. Tobias.
NCT02704351 is a clinical trial that has completed, run by Joseph D. Tobias. The registered enrollment target is 14 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02704351 has completed, sponsored by Joseph D. Tobias.
- COMPLETED
- Registry status
- 14 participants
- Enrollment target
Study Summary
The purpose of this study is to retrospectively review our preliminary experience during a surgical trip to Tuxtla, Mexico, using suggamadex to reverse neuromuscular blockade following CPB and cardiac surgery for repair of CHD in infants and children.
Interventions
- PROCEDURE Surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2016-02 |
| Est. Completion | 2016-08 |
What the finished NCT02704351 record still lists
NCT02704351 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 14 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Surgery is the first listed.
NCT02704351 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02704351 about?
NCT02704351 is a clinical study titled "Suggamadex and Fast-track Cardiac Anesthesia in a Developing Country". The purpose of this study is to retrospectively review our preliminary experience during a surgical trip to Tuxtla, Mexico, using suggamadex to reverse neuromuscular blockade following CPB and cardiac surgery for repair of CHD in infants and children.
What is the current status of trial NCT02704351?
This trial is currently completed. The enrollment target is 14 participants. The study started on 2016-02. Estimated completion is 2016-08.
What interventions are being tested in trial NCT02704351?
The interventions under investigation include: Surgery (PROCEDURE).
Who is sponsoring clinical trial NCT02704351?
This trial is sponsored by Joseph D. Tobias, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia